The Plot Twist Nobody Expected
So we've all heard the hype about GLP-1 medications like Ozempic and Wegovy. They're basically everywhere right now—in celebrity gossip columns, TikTok videos, and your friend group's group chat. But here's what's interesting: most of the excitement focuses on whether you lose weight, not how much weight matters.
A new study from researchers at the University of Liverpool decided to dig into that exact question with real-world data. And spoiler alert: the answer is pretty compelling.
The Study That Made Me Say "Oh, That Makes Sense"
Researchers looked at nearly 90,000 people in the United States who started taking GLP-1 medications between 2021 and 2024. We're talking about household names here—Ozempic, Wegovy, Mounjaro, and Saxenda. The average patient was 57 years old, already dealing with type 2 diabetes, and had a BMI that put them firmly in the obese category.
But here's where it gets real: almost half of these people quit taking their medication within a year. I know, I know—that's wild. But the researchers followed everyone anyway, which actually makes the findings even more trustworthy because it reflects real life, not some perfect lab scenario.
The Math That Matters
Let me break down what happened during that first year:
About 27% of people barely lost any weight (less than 5% BMI reduction). Another 22% got some decent results with a 5-10% reduction. Only 15% hit what you'd call a real success—15% or more BMI reduction. And then there's that uncomfortable 21% who actually gained weight.
Fast forward another 11 months or so, and the researchers checked in on how many people developed serious health problems like osteoarthritis, kidney disease, sleep apnea, or heart failure.
Here's Where It Gets Impressive
The difference between those who lost a lot of weight and those who barely lost any? Huge.
People who knocked off 15% or more of their BMI saw their risk of osteoarthritis drop by 37%. That's not nothing—that's actually life-changing for someone dealing with joint pain. Chronic kidney disease risk dropped 30%. Sleep apnea? Down 69%. That one blew me away because sleep apnea is genuinely miserable.
Even heart failure risk showed a 32% reduction, though the researchers noted this one didn't quite hit their statistical significance threshold (basically, they want to be extra sure before claiming victory on that front).
The Scary Opposite Side
Now here's the part that should get everyone's attention: people who gained weight while on these medications didn't just stay the same—they got worse.
Compared to minimal weight loss, weight gain led to:
- 10% higher osteoarthritis risk
- 14% higher kidney disease risk
- 22% higher sleep apnea risk
- A shocking 69% higher heart failure risk
That last number is the real attention-getter. Your heart is basically saying, "Thanks for nothing."
What This Actually Means for Real People
Look, I think this study is important because it strips away the oversimplification. These medications aren't magic wands. They're tools. And like any tool, how well they work depends on what you actually do with them.
The fact that half the people stopped taking their medications tells us something important too: these drugs aren't easy. They have side effects. They're expensive. And apparently, lots of people decide it's not worth continuing. But this study suggests that if you're going to take them, sticking with it and actually achieving meaningful weight loss is where the real benefits show up.
The people who lost significant weight? They're genuinely reducing their risk of diseases that could seriously impact their quality of life. The people who gained weight? They might actually be making things worse, possibly because they're on medication while simultaneously gaining weight—a pretty rough combination.
The Bigger Picture
What I find most honest about this research is that it doesn't pretend real-world situations are perfect. Half the patients quit. Weight loss varied wildly. And they analyzed everyone anyway, which means we're not looking at cherry-picked "success stories."
If you're considering these medications, this suggests you need to go in with realistic expectations: they can help, but you have to actually use them, and the more weight you successfully lose, the better your health outcomes will be. That's not revolutionary, but it's also not nothing.
Source: https://www.sciencedirect.com/science/article/pii/example